TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Dedicare Life Science AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,066
|
5,066
|
5,361 |
| Financial expenses |
2
|
1
|
0 |
| Earnings before taxes |
207
|
1,021
|
1,042 |
| EBITDA |
194
|
1,022
|
1,045 |
| Total assets |
1,107
|
1,598
|
1,771 |
| Current assets |
1,107
|
1,598
|
1,768 |
| Current liabilities |
302
|
781
|
940 |
| Equity capital |
805
|
817
|
831 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
16
|
23
|
17 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
72.7%
|
51.1%
|
46.9% |
| Turnover per employee |
192
|
220
|
315 |
| Profit as a percentage of turnover |
6.8%
|
20.2%
|
19.4% |
| Return on assets (ROA) |
18.9%
|
64.0%
|
58.8% |
| Current ratio |
366.6%
|
204.6%
|
188.1% |
| Return on equity (ROE) |
25.7%
|
125.0%
|
125.4% |
| Change turnover |
-2,015
|
139
|
2,248 |
| Change turnover % |
-40%
|
3%
|
72% |
| Chg. No. of employees |
-7
|
6
|
3 |
| Chg. No. of employees % |
-30%
|
35%
|
21% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.